ContraFect Corporation is a biotech company working on innovative treatment approaches for serious and life-threatening infectious diseases. With a focus on developing potent and targeted therapies, ContraFect aims to address the growing issue of antimicrobial resistance. Through its cutting-edge technology, the company is poised to make a significant impact in the field of infectious disease therapeutics.
Notification